Disappearance of minimal residual disease after the early withdrawal of immunosuppressants in a patient with juvenile myelomonocytic leukemia

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Combined Modality Therapy
• Female
• Graft vs Host Disease / prevention & control*
• Hematopoietic Stem Cell Transplantation
• Humans
• Immunosuppressive Agents / metabolism*
• Immunosuppressive Agents / therapeutic use*
• In Situ Hybridization, Fluorescence
• Infant
• Leukemia, Myelomonocytic, Juvenile / genetics
• Leukemia, Myelomonocytic, Juvenile / therapy*
• Neoplasm, Residual / genetics
• Neoplasm, Residual / prevention & control*
• Remission Induction